Published in Gut Microbes on June 03, 2011
SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains. PLoS Pathog (2014) 1.47
Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-binding protein BBK32 is required for optimal infectivity. Mol Microbiol (2011) 1.08
In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med (2013) 0.99
Bioluminescence imaging study of spatial and temporal persistence of Lactobacillus plantarum and Lactococcus lactis in living mice. Appl Environ Microbiol (2012) 0.93
In vivo bioluminescence imaging of Escherichia coli O104:H4 and role of aerobactin during colonization of a mouse model of infection. BMC Microbiol (2012) 0.85
Roles and regulation of the mucus barrier in the gut. Tissue Barriers (2015) 0.84
Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogens. Mol Imaging Biol (2015) 0.83
Bioluminescent Imaging Reveals Novel Patterns of Colonization and Invasion in Systemic Escherichia coli K1 Experimental Infection in the Neonatal Rat. Infect Immun (2015) 0.81
In Vivo and In Vitro Detection of Luminescent and Fluorescent Lactobacillus reuteri and Application of Red Fluorescent mCherry for Assessing Plasmid Persistence. PLoS One (2016) 0.79
Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells. Infect Immun (2013) 0.79
The serine protease Pic as a virulence factor of atypical enteropathogenic Escherichia coli. Gut Microbes (2016) 0.78
Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo. Infect Immun (2014) 0.78
In Vivo Imaging Demonstrates That Borrelia burgdorferi ospC Is Uniquely Expressed Temporally and Spatially throughout Experimental Infection. PLoS One (2016) 0.76
Vaccination with DNA Encoding Truncated Enterohemorrhagic Escherichia coli (EHEC) Factor for Adherence-1 Gene (efa-1') Confers Protective Immunity to Mice Infected with E. coli O157:H7. Front Cell Infect Microbiol (2016) 0.75
Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulators. Sci Rep (2016) 0.75
Mutation of the Enterohemorrhagic Escherichia coli Core LPS Biosynthesis Enzyme RfaD Confers Hypersusceptibility to Host Intestinal Innate Immunity In vivo. Front Cell Infect Microbiol (2016) 0.75
Murine immunization with CS21 pili or LngA major subunit of enterotoxigenic Escherichia coli (ETEC) elicits systemic and mucosal immune responses and inhibits ETEC gut colonization. Vet Microbiol (2016) 0.75
Reporter systems for in vivo tracking of lactic acid bacteria in animal model studies. Gut Microbes (2015) 0.75
Giardia Colonizes and Encysts in High-Density Foci in the Murine Small Intestine. mSphere (2017) 0.75
EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity. Cell Microbiol (2017) 0.75
Photonic detection of bacterial pathogens in living hosts. Mol Microbiol (1995) 5.24
Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science (2004) 2.58
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol (2007) 2.31
Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol (2004) 2.18
In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect Immun (2006) 2.07
Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev (2003) 2.01
Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe (2008) 1.71
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun (1999) 1.66
Successful small intestine colonization of adult mice by Vibrio cholerae requires ketamine anesthesia and accessory toxins. PLoS One (2009) 1.42
Real-time monitoring of Escherichia coli O157:H7 adherence to beef carcass surface tissues with a bioluminescent reporter. Appl Environ Microbiol (1999) 1.40
Emergence of a 'hyperinfectious' bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract. Cell Microbiol (2005) 1.25
Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation. Mol Microbiol (2010) 1.18
Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner. Lab Invest (2010) 1.06
Monitoring of Yersinia enterocolitica in murine and bovine feces on the basis of the chromosomally integrated luxAB marker gene. Appl Environ Microbiol (1992) 1.02
Ketamine/xylazine attenuates LPS-induced iNOS expression in various rat tissues. J Surg Res (2003) 0.97
Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR. FEMS Immunol Med Microbiol (2009) 0.95
Ketamine suppresses endotoxin-induced NF-kappaB activation and cytokines production in the intestine. Acta Anaesthesiol Scand (2004) 0.92
Ketamine inhibits transcription factors activator protein 1 and nuclear factor-kappaB, interleukin-8 production, as well as CD11b and CD16 expression: studies in human leukocytes and leukocytic cell lines. Anesth Analg (2010) 0.90
Analysis of Yersinia enterocolitica invasin expression in vitro and in vivo using a novel luxCDABE reporter system. Microbiology (2010) 0.90
HosA, a member of the SlyA family, regulates motility in enteropathogenic Escherichia coli. Infect Immun (2005) 0.84
Bioluminescent monitoring of in vivo colonization and clearance dynamics by light-emitting bacteria. Methods Mol Biol (2009) 0.84
Bacteria-host communication: the language of hormones. Proc Natl Acad Sci U S A (2003) 4.38
Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol Microbiol (2002) 3.48
Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol (2003) 3.35
The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol Microbiol (2002) 2.75
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology (2002) 2.66
Identification and characterization of lpfABCC'DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7. Infect Immun (2002) 2.18
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog (2010) 2.03
Multiple elements controlling adherence of enterohemorrhagic Escherichia coli O157:H7 to HeLa cells. Infect Immun (2003) 1.97
StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol Microbiol (2002) 1.92
Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun (2005) 1.89
Quorum-sensing Escherichia coli regulator A: a regulator of the LysR family involved in the regulation of the locus of enterocyte effacement pathogenicity island in enterohemorrhagic E. coli. Infect Immun (2002) 1.88
Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci U S A (2007) 1.80
Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli. J Clin Invest (2007) 1.72
Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment. Anesthesiology (2012) 1.67
Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest (2006) 1.66
Synergistic role of curli and cellulose in cell adherence and biofilm formation of attaching and effacing Escherichia coli and identification of Fis as a negative regulator of curli. Environ Microbiol (2009) 1.65
GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2. Mol Microbiol (2011) 1.55
Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect Immun (2003) 1.49
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proc Natl Acad Sci U S A (2011) 1.46
Long polar fimbriae contribute to colonization by Escherichia coli O157:H7 in vivo. Infect Immun (2004) 1.44
Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect Immun (2004) 1.44
Characterization of the second long polar (LP) fimbriae of Escherichia coli O157:H7 and distribution of LP fimbriae in other pathogenic E. coli strains. FEMS Microbiol Lett (2004) 1.43
Temporal expression of enteropathogenic Escherichia coli virulence genes in an in vitro model of infection. Infect Immun (2005) 1.41
Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol Microbiol (2005) 1.40
Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7. J Clin Invest (2007) 1.39
Subepidermal bullous dermatosis associated with IgA multiple myeloma: a case report. Am J Dermatopathol (2013) 1.39
An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers. Proc Natl Acad Sci U S A (2007) 1.38
Characterization of Cah, a calcium-binding and heat-extractable autotransporter protein of enterohaemorrhagic Escherichia coli. Mol Microbiol (2002) 1.32
SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun (2005) 1.32
Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res (2010) 1.32
Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2005) 1.32
Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell Microbiol (2006) 1.29
Injectable nano-network for glucose-mediated insulin delivery. ACS Nano (2013) 1.26
Pathogenic Escherichia coli. Int J Med Microbiol (2005) 1.26
Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences. Infect Immun (2003) 1.23
Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat Rev Microbiol (2008) 1.22
Etiology of acute diarrhea in adults in southwestern Nigeria. J Clin Microbiol (2003) 1.21
Long polar fimbriae and tissue tropism in Escherichia coli O157:H7. Microbes Infect (2006) 1.20
The N-terminus of enteropathogenic Escherichia coli (EPEC) Tir mediates transport across bacterial and eukaryotic cell membranes. Mol Microbiol (2002) 1.19
Nucleotide sequence analysis of the enteropathogenic Escherichia coli adherence factor plasmid pMAR7. Infect Immun (2006) 1.19
Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor. Clin Cancer Res (2008) 1.19
Identification of single nucleotide polymorphisms and haplotypes associated with yield and yield components in soybean (Glycine max) landraces across multiple environments. Theor Appl Genet (2011) 1.17
SepL, a protein required for enteropathogenic Escherichia coli type III translocation, interacts with secretion component SepD. Mol Microbiol (2004) 1.17
Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level. Am J Physiol Gastrointest Liver Physiol (2005) 1.17
A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspF. Infect Immun (2002) 1.15
The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity. Cell Microbiol (2008) 1.14
The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell Microbiol (2009) 1.14
The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. coli. J Bacteriol (2009) 1.13
Fabrication of flexible and freestanding zinc chalcogenide single layers. Nat Commun (2012) 1.13
Unraveling metal-insulator transition mechanism of VO₂ triggered by tungsten doping. Sci Rep (2012) 1.13
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes (2012) 1.12
Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48. Infect Immun (2004) 1.12
A dimeric structure of PD-L1: functional units or evolutionary relics? Protein Cell (2010) 1.11
Painting blood vessels and atherosclerotic plaques with an adhesive drug depot. Proc Natl Acad Sci U S A (2012) 1.09
Hfq affects the expression of the LEE pathogenicity island in enterohaemorrhagic Escherichia coli. Mol Microbiol (2009) 1.08
ToxR interferes with CRP-dependent transcriptional activation of ompT in Vibrio cholerae. Mol Microbiol (2002) 1.07
Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-kappaB activation. Infect Immun (2008) 1.07
Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner. Lab Invest (2010) 1.06
Relative evolutionary rates of NBS-encoding genes revealed by soybean segmental duplication. Mol Genet Genomics (2010) 1.06
Genetic diversity of the gene cluster encoding longus, a type IV pilus of enterotoxigenic Escherichia coli. J Bacteriol (2007) 1.05
The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection. Cell Microbiol (2008) 1.05
Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery. ACS Nano (2013) 1.04
A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells. Cancer Biol Ther (2008) 1.04
Identification and characterization of the locus for diffuse adherence, which encodes a novel afimbrial adhesin found in atypical enteropathogenic Escherichia coli. Infect Immun (2005) 1.01
Effect on human cells of environmental Vibrio parahaemolyticus strains carrying type III secretion system 2. Infect Immun (2010) 1.01
Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis. Am J Physiol Gastrointest Liver Physiol (2008) 1.01
Identification of genomic regions determining flower and pod numbers development in soybean (Glycine max L.). J Genet Genomics (2010) 1.01
Mouse model of enteropathogenic Escherichia coli infection. Infect Immun (2005) 0.99
LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence. PLoS One (2011) 0.99
Women in gastroenterology: exciting times and trends. Gastroenterology (2008) 0.99
Enteropathogenic Escherichia coli O125:H6 triggers attaching and effacing lesions on human intestinal biopsy specimens independently of Nck and TccP/TccP2. Infect Immun (2007) 0.99
Urease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor. Infect Immun (2002) 0.98
Fitness cost of the green fluorescent protein in gastrointestinal bacteria. Can J Microbiol (2003) 0.98
Floral transcriptome sequencing for SSR marker development and linkage map construction in the tea plant (Camellia sinensis). PLoS One (2013) 0.97
PKC zeta participates in activation of inflammatory response induced by enteropathogenic E. coli. Am J Physiol Cell Physiol (2003) 0.97
Enterohemorrhagic E. coli requires N-WASP for efficient type III translocation but not for EspFU-mediated actin pedestal formation. PLoS Pathog (2010) 0.97
Rapid activation of Na+/H+ exchange by EPEC is PKC mediated. Am J Physiol Gastrointest Liver Physiol (2006) 0.97
Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect (2006) 0.96
Post-transcriptional processing of the LEE4 operon in enterohaemorrhagic Escherichia coli. Mol Microbiol (2008) 0.96
Pits confined in ultrathin cerium(IV) oxide for studying catalytic centers in carbon monoxide oxidation. Nat Commun (2013) 0.96
Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection. Cell Microbiol (2004) 0.96
Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord. Mol Pain (2011) 0.95
Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion. Eur J Pharmacol (2008) 0.95
Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR. FEMS Immunol Med Microbiol (2009) 0.95
Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug. Biomaterials (2013) 0.94
The Escherichia coli phosphotyrosine proteome relates to core pathways and virulence. PLoS Pathog (2013) 0.94
The Escherichia coli ycbQRST operon encodes fimbriae with laminin-binding and epithelial cell adherence properties in Shiga-toxigenic E. coli O157:H7. Environ Microbiol (2009) 0.93
Low overpotential in vacancy-rich ultrathin CoSe2 nanosheets for water oxidation. J Am Chem Soc (2014) 0.93
The lpf gene cluster for long polar fimbriae is not involved in adherence of enteropathogenic Escherichia coli or virulence of Citrobacter rodentium. Infect Immun (2006) 0.93
A computer program for estimating the re-transformed mean in heteroscedastic two-part models. Comput Methods Programs Biomed (2008) 0.93
Genome-wide identification and characterization of putative cytochrome P450 genes in the model legume Medicago truncatula. Planta (2007) 0.93
Localized delivery of dexamethasone from electrospun fibers reduces the foreign body response. Biomacromolecules (2012) 0.91
Interspecies communication in the gut, from bacterial delivery to host-cell response. J Physiol (2011) 0.91
Optimization of optical excitation of upconversion nanoparticles for rapid microscopy and deeper tissue imaging with higher quantum yield. Theranostics (2013) 0.90